Balance Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Balance Wealth's REGN Position: Q3 2026 in Review
Balance Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 14 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #546 among its holdings.
1,409 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Balance Wealth held 14 shares of Regeneron Pharmaceuticals worth $10.7K as of Q3 2026.
- Regeneron Pharmaceuticals was a new Balance Wealth position in Q3 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Balance Wealth's portfolio in Q3 2026, its #546 holding.
- 1,409 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.